PubMed

Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study.

Cryer DR, Nicholas SP, Henry DH, Mills DJ, Stadel BV.

Diabetes Care. 2005 Mar;28(3):539-43.PMID: 15735184 [PubMed - indexed for MEDLINE]Related articlesFree article

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter S, Greyber E, Pasternak G, Salpeter E.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002967. Review.PMID: 16437448 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

Lewin A, Lipetz R, Wu J, Schwartz S.

Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.

Kamber N, Davis WA, Bruce DG, Davis TM.

Med J Aust. 2008 Apr 21;188(8):446-9.PMID: 18429709 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.

Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CA.

Drugs Aging. 2008;25(7):611-22.PMID: 18582148 [PubMed - indexed for MEDLINE]Related articles

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

[Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs]

Scheen AJ.

Rev Med Liege. 2002 May;57(5):352-6. French. PMID: 12143186 [PubMed - indexed for MEDLINE]Related articles

Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.

Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M.

Cardiology. 1999;91(3):195-202.PMID: 10516414 [PubMed - indexed for MEDLINE]Related articles

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

Salpeter SR, Greyber E, Pasternak GA, Salpeter EE.

Arch Intern Med. 2003 Nov 24;163(21):2594-602. Review.PMID: 14638559 [PubMed - indexed for MEDLINE]Related articlesFree article

Do risk factors for lactic acidosis influence dosing of metformin?

Millican S, Cottrell N, Green B.

J Clin Pharm Ther. 2004 Oct;29(5):449-54.PMID: 15482389 [PubMed - indexed for MEDLINE]Related articles

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR.

Diabetes Care. 2008 Nov;31(11):2086-91. Epub 2008 Sep 9.PMID: 18782901 [PubMed - indexed for MEDLINE]Related articlesFree article

Lactic acidosis rates in type 2 diabetes.

Brown JB, Pedula K, Barzilay J, Herson MK, Latare P.

Diabetes Care. 1998 Oct;21(10):1659-63. Erratum in: Diabetes Care 1998 Dec;21(12):2203. PMID: 9773726 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.

Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA.

Diabetes Care. 2005 Oct;28(10):2345-51.PMID: 16186261 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride.

Rubin CJ, Ledeine JM, Fiedorek FT.

Diab Vasc Dis Res. 2008 Sep;5(3):168-76.PMID: 18777489 [PubMed - indexed for MEDLINE]Related articles